Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1K70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,516
Award facts
- Contract value 100% obligated
- $122,515.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $122,515.80 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens. The contract is firm fixed price with no set-aside designation and is scheduled for completion by November 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.9 million ceiling and extends through December 2026.
Dupixent (dupilumab) is a biologic therapeutic indicated for various allergic and inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order reflects the DLA's ongoing need to supply specialized pharmaceutical products to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements across multiple therapeutic domains, with the company consistently delivering both brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F1K70?
SPE2DR26F1K70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F1K70 worth?
The government has obligated $122,516 on SPE2DR26F1K70.
Is contract SPE2DR26F1K70 an order under another contract?
Yes. SPE2DR26F1K70 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1K70 competed?
The extent of competition for SPE2DR26F1K70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award